Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment
Completed · Not applicable
Conditions studied: Primary Open-angle Glaucoma
In brief
The purpose of this study is to develop an educational program that will help improve the patients' understanding of what laser treatment is, how it might be beneficial to them, and why it should be the first eye pressure lowering glaucoma treatment to consider before the use of glaucoma eye drops.
Key facts
- Study ID
- NCT03365778
- Run by
- Wills Eye
- People needed
- 86
- Starts
- 2017-10-23
- Expected to finish
- 2019-12-31
- Last updated by the study team
- 2020-01-30
Who can join
Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients between 40 and 90 years of age
- high-risk ocular hypertension, primary open-angle glaucoma, or pseudo-exfoliation glaucoma
- currently treated with at least one glaucoma eye drop with stable intraocular pressure
You may not qualify if…
- previous laser trabeculoplasty
- previous glaucoma surgery
Where it is running
- Wills Eye Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.